Descriptive epidemiology of hepatitis C virus infection in France in 1996;Epidemiologie descriptive de l'infection par le virus de l'hepatite C en France en 1996

Transfusion Clinique et Biologique

Volumn 4, Issue 3, 1997, Pages 299-319

  Lefrere J J ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

epidemiology; genotypes; hepatitis C virus; prevalence

Indexed keywords

CONFERENCE PAPER; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PREVALENCE; VIRUS TRANSMISSION; BLOOD TRANSFUSION; CROSS INFECTION; DISEASE TRANSMISSION; FEMALE; FRANCE; GENETICS; MALE; REVIEW; RISK FACTOR;

BLOOD TRANSFUSION; CROSS INFECTION; FEMALE; FRANCE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; PREVALENCE; RISK FACTORS;

EID: 0030917748     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1246-7820(97)80056-0     Document Type: Conference Paper

References (111)

1. Choo Q, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A non-B viral hepatitis genome. Science, 1989; 244: 359-362.
2. Mizokami M, Ina Y, Ohba K, Ohno T, Suzuki K, Onto E et al. Molecular evolutional genotypes of hepatitis C virus and their divergence times. In: Scientific Program and Abstract Volume of the International Symposium on viral hepatitis and liver disease, 8th Triennal Congress, Tokyo, 1993: 75.
3. Pawlotsky JM, Lunel F. Le virus de l'hépatite C. In : Lefrère JJ, ed. Les virus transmissibles par le sang. Paris: John Libbey Eurotext, 1996: 23-52.
4. Alter HJ, Purcell RH, Shih JW. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-1500.
5. Nelson KE, Donahue JG, Stambolis V. Post-transfusion hepatitis C virus infection. N Engl J Med 1992; 328: 1601-1602.
6. Kuo G, Choo QL, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364.
7. Donahue JG, Munoz A, Ness PM et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373.
8. Blajchman MA, Bull SB, Feinman SV, for the Canadian Post-Transfusion Hepatitis Prevention Study Group. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Lancet 1995; 345: 21-25.
9. Micoud M. Rapport sur l'hépatite C en France. Ministère de la Santé et de l'action humanitaire, 1993.
10. DeMontalembert M, Costagliola D, Lefrère JJ et al. Study of the persistent risk of transfusional viral infections through a sentinel cohort of multitransfused thalassemic patients. Transfusion 1992; 32: 509-512.
11. DeMontalembert M, Girot R, Mattlinger B, Lefrère JJ. Transfusion-dependent thalassemia: viral complications (Epidemiology and follow-up). Semin Hematol 1995; 32: 280-287.
12. Blanchette VS, Vorstman E, Shore A, Wang E, Petric M, Jett W et al. Hepatitis C infection in children with hemophilia A and B. Blood 1991; 78: 285-289.
13. Tedder RS, Briggs M, Ring C, Tuke PW, Jones P, Savidge G et al. Hepatitis C antibody profile and viraemia prevalence in adults with severe hemophilia. Br J Haematol 1991; 79: 512-515.
14. Troisi CL, Hollinger FB, Hoots WK. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993; 81: 412-418.
15. Maisonneuve P, Couroucé AM, Ferrer-le-Cœur F. Anti-VHC et receveurs: situation chez les hémophiles en 1991. Rev Fr Transf Hémobiol 1992; 35: 193-198.
16. Yap PL, McOmish F, Webster ADB et al. Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol 1994; 21: 455-460.
17. Lefrère JJ, Mariotti M, Trepo C et al. Searching for HCV-RNA by PCR in commercial intravenous immunoglobulins. Lancet 1993; 341: 834-835.
18. Lefrère JJ, Loiseau P, Martinot-Peignoux P et al. Infection by hepatitis C virus through contaminated intravenous immune globulin Gammagard: results of a national prospective inquiry. Transfusion 1996; 36: 394-397.
19. Power JP, Lawlor E, Davidson F. Hepatitis C viremia in recipients of Irish intravenous anti-D immunoglobulin. Lancet 1994; 344: 1166-1167.
20. Schiff RI. Transmission of viral infections through intravenous immune globulin. N Engl J Med 1994; 331: 1649-1650.
21. Jullien AM. Hépatite C en pratique transfusionnelle. Med Mal Infect 1995; 25: 1074-1083.
22. Couroucé AM, Pillonel J. Estimation du risque de transmission des virus des hépatites B et C, et des rétrovirus par transfusion de dérivés sanguins labiles. BEH 1996; 11: 54-55.
23. Riggert J, Schwartz DWM, Simson A et al. Risk of hepatitis C virus (HCV) transmission by anti-HCV-negative blood components in Austria and Germany. Ann Hematol 1996; 72: 35-39.
24. Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs intravenous drug use. Hepatology 1993; 18: 1338-1343.
25. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J et al. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 1607-1610.
26. Lucidarme D, Foutrein P, Creusy C. Prévalence des marqueurs des hépatites C, B et D et aspects histopathologiques dans un groupe de toxicomanes intraveineux. Gastroentrol Clin Biol 1994; 18: 964-968.
27. Carpentier C, Costes JM. Drogues et toxicomanies: indicateurs et tendances. Direction générale à la lutte contre la drogue et la toxicomanie. Observatoire Français des drogues et des toxicomanies, Paris, 1995.
28. Foutrein P, Lucidarme D, Muyssen A et al. Prévalence des hépatites B et C et du VIH dans une population de toxicomanes intraveineux de l'agglomération lilloise. Gastroenterol Clin Biol 1993; 17: A282.
29. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237-241.
30. Stark K, Schreier E, Muller R, Wirth D, Driesel G, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 1995; 27: 331-337.
31. Conry-Cantilena C, VanRaden M, Gibble J et al. Routes of infection, viremia, and liver disease in blood donors to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.
32. Pol S, Thiers V, Nousbaum JB, Legendre C, Berthelot P, Kreis H et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995; 108: 581-583.
33. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F et al. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100.
34. Yamaguchi K, Nishimura Y, Fukuoka N, Machida J, Ueda S, Kusumoto Y et al. Hepatitis C virus antibodies in haemodialysis patients. Lancet 1990; 335: 1409-1410.
35. Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE et al. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1992; 41: 1055-1058.
36. Simon N. Virus de l'hépatite C en hémodialyse. Path Biol 1995; 8: 735-740.
37. Simon N, Couroucé AM, Lemarrec N, Trepo C, Ducamps S. A twelve year natural history of hepatitis C virus infection in hemodialyzed patients. Kidney Int 1994; 46: 504-511.
38. Chan TM, Suk Fong Lok A, Kum Po Cheng I, Tzun Chan R. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.
39. Bukh J, Wantzin P, Krogsgaard K et al. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercial available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis 1993; 168: 1343-1348.
40. Jadoul M, Cornu C, VanYpersele de Strihou C, and the UCL Collaborative Group. Incidence and risk factors for hepatitis C seroconversion in hemodialysis. Kidney Int 1993; 44: 1322-1326.
41. Allander T, Gruber A, Naghavi M et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603-607.
42. Allander T, Medin C, Jacobson SH, Grillner L, Persson MAA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994; 43: 415-419.
43. Pereira BJG, Milford DL, Kirman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991; 325: 4454-4460.
44. Pereira B, Milford E, Kirkman R, Quan S, Sayre K, Johnson P, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 324: 910-915.
45. Lefrère JJ, Sellami F, Larderie P, Lemaillot C, Roudot-Thoraval F, Claquin J. Six years of experience in virus screening of organ donors in France. Transfusion, in press.
46. Lunel F, Cadranel JF, Perrin M et al. Anti-hepatitis C virus (HCV) antibodies in heart transplant recipients with post-transplantation chronic viral B and non-A, non-B hepatitis. Dig Dis Sci 1991; 36: 124-125.
47. Pereira BJG, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484-487.
48. Esteban JI, Gomez J, Martell M. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-560.
49. Laboratory Centre for Disease Control. Guidelines and recommendations on the prevention and control for hepatitis C. Can J Gastroenterol 1995; 9: 377-386.
50. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D. Risque de transmission du virus de l'hépatite C par l'endoscopie digestive. Gastroentérol Clin Biol 1995; 19: 346-349.
51. Tennenbaum R, Colardelle P, Chochon M, Maisonneuve P, Jean F, Andrieu J. Hépatite C après cholangiographie rétrograde. Gastroenterol Clin Biol 1993; 17: 763-764.
52. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D. Risque de transmission du virus de l'hépatite C par l'endoscopie digestive. Gastroenterol Clin Biol 1995; 19: 346-349.
53. Andrieu J, Barny S, Colardelle P. Prévalence et facteurs de risque de l'infection par le virus de l'hépatite C dans une population hospitalisée en gastroentérologie. Gastroentérol Clin Biol 1995; 19: 340-345.
54. Couroucé AM and the French Bloood Transfusion Centers: seroconversion to HCV in blood donors. European Congress of the International Society of Blood Transfusion, Venice, 1995: 127.
55. Suzuki K, Mizokami M, Lau JY et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 1994; 170: 1575-1578.
56. er mars 1995, prévention. Bull Epidemiol Hebdo 1995; 37: 166-167.
57. Kiyosawa K, Sodeyama T, Tanaka E et al. Hepatitis C in hospital employees with needletick injuries. Ann Inter Med 1991; 115: 367-369.
58. Germanaud J, Causse X, Dhumeaux D. Transmission de l'hépatite C lors des piqûres accidentelles. Évaluation du risque. Presse Med 1994; 23: 1078-1082.
59. Mitsui T, Iwano K, Masuko K et al. Hepatitis C virus infection in medical personel after needlestick accident. Hepatology 1992; 16: 1109-1114.
60. Klein RS, Freeman K, Taylor PE, Stevens CE. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991; 338: 1539-1542.
61. Brettler DB, Mannucci PM, Gringeri A. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood 1992; 80: 540-543.
62. Scotto G, Savastano AM, Fazio V, Conte PE, Ferrara S, Mangano A et al. Sexual transmission of hepatitis C virus infection. Eur J Epidemiol 1996; 12: 241-244.
63. Bresters D, Mauser-Bunschoten EP, Reesink HW et al. Sexual transmission of hepatitis C virus. Lancet 1993; 342: 210-211.
64. Puotti C, Magrini A, Filippi T, Aldegheri L. Do symptomless HCV carriers spread infection to their relatives (letter). Lancet 1995; 346: 843.
65. Riestria S, Suarez A, Rodrigo L. Transmission of hepatitis C virus. Ann Intern Med 1990; 113: 411-412.
66. Tedder RS, Gilson RJC, Briggs M et al. Hepatitis C virus: evidence for sexual transmission. Br Med J 1991; 302: 1299-1302.
67. Lissen E, Alter HJ, Abad MA et al. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis 1993; 12: 827-831.
68. Buchbinder SP, Katz MH, Hessol NA, Liu J, O'Malley PM, Alter MJ. Hepatitis C virus infection in sexually active homosexual men. J Infect 1994; 29: 263-269.
69. Nakashima K, Kashiwagi S, Hayashi J et al. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol 1992; 16: 1132-1137.
70. Stary A, Kopp W, Hofmann H, Heller-Vitouch C, Kunz C. Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Trans Dis 1992; 19: 252-258.
71. Osmond DH, Charlebois E, Sheppard HW et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167: 66-71.
72. Weinstock HS, Bolan G, Reingold AI, Polish LB. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993; 269: 394.
73. Diago M, Zapater R, Tuset C et al. Intrafamily transmission of hepatitis C virus: sexual and non-sexual contacts. J Hepatol 1996; 25: 125-128.
74. Rice PS, Smith DB, Simmonds P, Holmes E. Heterosexual transmission of hepatitis C virus. Lancet 1993; 342: 1052-1053.
75. Shev S, Hermodsson S, Lindholm A, Malm E, Widell A, Norkrans G. Risk factor exposure among hepatitis C virus RNA positive swedish blood donors. The role of parenteral and sexual transmission. Scand J Infect Dis 1995; 27: 99-104.
76. Utsumi T, Hashimoto E, Okumura Y et al. Heterosexual activity as a risk factor for the transmission of hepatitis C virus. J Med Virol 1995; 46: 122-125
77. Soto B, Rodrigo L, Garcia-Bengoecha M et al. Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings. J Intern Med 1994; 236: 515-519.
78. Silverman AL, Puccio JE, Kulesza GN, McGray DG, Gordon SC. HCV RNA is present in the menstrual blood of women with chronic hepatitis C infection. Am J Gastroenterol 1994; 89: 1201-1202.
79. Lefrère JJ and the GEMHEP. Multicentre quality control of hepatitis C virus RNA polymerase chain reaction. In: Groupe Français d'Études Moléculaires des Hépatites (GEMHEP). Hepatitis C virus: new diagnostic tools. Paris, John Libbey Eurotext: 1994: 49-56.
80. Chang TT, Liou TC, Young KC et al. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994; 42: 91-96.
81. David XR, Blanc P, Pageaux GP et al. Transmission familiale du virus de l'hépatite C. Gastroenterol Clin Biol 1995; 19: 150-155.
82. Couzigou P. Sexe, famille et virus de l'hépatite C. Association prouvée, causalité non établie. Gastroenterol Clin Biol 1995; 19: 147-149.
83. Buscarini E, Tanzi E, Zanetti AR et al. High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV positive chronic liver disease. Scand J Gastroenterol 1993; 28: 343-346.
84. Camarero C, Martos I, Delgado R, Suarez L, Escobar H, Mateos M. Horizontal transmission of hepatitis C virus in households of infected children. J Pediatr 1993; 123: 98-99.
85. David XR, Blanc P, Pageaux GP et al. Transmission intrafamiliale du virus de l'hépatite C. Gastroenterol Clin Biol 1995; 19: 150-155.
86. Tumminelli F, Marcellin P, Rizzo S, Barbera S, Corvino G, Furia P et al. Shaving as potential source of hepatitis C virus infection (letter). Lancet 1995; 345: 658.
87. Giovanni M, Tagger A, Ribero MJ, Zucotti G, Pogliani L, Grossi A et al. Maternal-infant transmission of hepatitis C virus and HIV infection: a possible interaction. Lancet 1990; 335: 1166.
88. Novati R, Thiers V, d'Arminio Monforte A, Lazzarin A, Bréchot C. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 1992; 165: 720-723.
89. Lam JPH, McOmish F, Burns SM, Yap LP, Mok JYQ, Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 167: 572-576.
90. Thaler MM, Park CK, Landers DV, Wara DW, Houghton M. Vertical transmission of hepatitis C virus. Lancet 1991; 338: 17-18.
91. Zanetti AR, Tanzi E, Paccagnini S. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on vertical HCV transmission. Lancet 1995; 345: 289-291.
92. Ohto H, Terasawa S, Sasaki N, Ishiwata C, Kako M, Ojhe N et al. and the Vertical Transmission of Hepatitis C Virus collaborative study group. N Engl J Med 1994; 330: 744-750.
93. Roudot-Thoraval F, Pawlotsky JM, Thiers V et al. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology 1993; 17: 772-777.
94. Inoue Y, Takeuchi K, Chou WH, Unayama T, Takahashi K, Saito I et al. Silent mother-to-child transmission of hepatitis C virus through two generations determined by comparative nucleotide sequence analysis of the viral cDNA. J Infect Dis 1992; 166: 1425-1428.
95. Ohto H, Terazawa S, Sasaki N et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744-750.
96. Roudot-Thoraval F, Pawlotsky JM, Dhumeaux D, et le Groupe d'Étude de la prévalence et de l'épidémiologie des hépatites C. Épidémiologie et morbidité du virus de l'hépatite C en France. Étude de 6 664 patients atteints d'hépatite chronique C. BEH 1996; 5: 20-21.
97. Lefrère JJ, Guiramand S, Lefrère F, Mariotti P, Aumont P, Petit JC et al. Full or partial seroreversion in hepatitis C virus infection. J Infect Dis 1997; 175: 316-322.
98. Dubois F, Desenclos JC, Mariotte N, Goudeau A et le Groupe d'Étude. Séroprévalence de l'infection par le virus de l'hépatite C dans un échantillon national d'assurés sociaux volontaires à un examen de santé de la Sécurité Sociale. BEH 1996; 5: 17-19.
99. Roudot-Thoraval F, Deforges L, Girollet PP, Maria B, Milliez J, Pathier D et al. Prévalences des anticorps dirigés contre le VHC (test Elisa et Riba 2) dans une population de femmes enceintes en France. Gastroentérol Clin Biol 1992; 16: 255-259.
100. Couturier E, Brossard Y, Rotily M, Obadia Y, Rey D, Larsen M et al. Séroprévalence des anticorps anti-VHC dans un échantillon exhaustif de femmes ayant terminé une grossesse en régions Ile-de-France - Alpes - Côte d'Azur. BEH 1996: 5.
101. Desenclos JC, Dubois F, Couturier E, Pillonel J, Roudot-Thoraval F, Guignard E et al. Estimation du nombre de sujets infectés par le VHC en France, 1994-1995. BEH 1996: 5.
102. Janot C, Couroucé AM, Maniez M. Antibodies to hepatitis C virus in French blood donors. Lancet 1989; 2: 796-797.
103. Simmons P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994; 19: 1321-1324.
104. Bréchot C. Hepatitis C virus genetic variability: clinical implications. In: Groupe Français d'Études Moléculaires des Hépatites (GEMHEP). Hepatitis C virus: new diagnostic tools. Paris: John Libbey Eurotext 1994: 1-16.
105. Stuyver L. HCV genotypes and genotyping methods. In: Groupe Français d'Études Moléculaires des Hépatites (GEMHEP). Hepatitis C virus: new diagnostic tools. Paris: John Libbey Eurotext 1994: 39-48.
106. Qu D, Hantz O, Gouy M et al. Heterogenity of hepatitis C virus genotypes in France. J Gen Virol 1994; 75: 1063-1070.
107. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchet C, and the Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-168.
108. Nousbaum JM, Pol S, Gigou M. HCV genotype II is associated to liver cirrhosis cancer and low response to interferon alpha in European patients. Hepatology 1993; 18: 88A.
109. Françoise Roudot-Thoraval, communication personnelle.
110. Farci P, Alter HJ, Govindarajan S et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135-140.
111. Gournay J, Marcellin P, Martinot-Peignoux P et al. Hepatitis C virus genotypes in French blood donors. J Med Virol 1995; 45: 399-404.